Emerging Trends in Glaucoma Management: Advancements in Diagnostic Modalities, Therapeutic Interventions, and Personalized Medicine Approaches

Glaucoma, a progressive optic neuropathy characterized by retinal ganglion cell degeneration and visual field loss, remains a leading cause of irreversible blindness worldwide. Recent advancements in imaging technologies, minimally invasive surgical techniques (MIGS), and neuroprotective therapies have revolutionized the diagnostic and therapeutic landscape of this multifactorial disease. This article explores contemporary trends in glaucoma care, including the integration of artificial intelligence (AI) in optical coherence tomography (OCT) analysis, the role of biomarkers in early detection, and the paradigm shift toward personalized treatment strategies. Additionally, we review novel pharmacological agents targeting intraocular pressure (IOP)-independent mechanisms, such as Rho kinase inhibitors and adenosine receptor agonists, as well as innovations in sustained-release drug delivery systems. The synthesis of current evidence underscores the importance of a multidisciplinary approach to optimize patient outcomes and mitigate disease progression in at-risk populations.